Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idursulfase-IT Extension in Hunter Syndrome
NCT01506141Phase 2Completed
- Sponsor
- Takeda
- Start
- Aug 2010
- Primary completion
- Apr 2024
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of idursulfase in mucopolysaccharidosis type II, sponsored by Takeda. Started Aug 2010; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT01506141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506141.